Heart Pharmacology

Cardiovascular pharmacology manages the medicine of heart maladies. The Cardiac Drugs are utilized to treat states of the identified with heart or the circulatory or vascular science . Numerous classes of cardiovascular specialists are accessible to treat the different cardiovascular conditions. The most usually utilized sub-classification drugs incorporate Sodium, potassium, calcium channel blockers, ACE-inhibitors and Cardiac biomarkers. There are predominantly 6 affiliations and social orders and the principle relationship for Cardiac Therapeutic Agents in USA. 50 colleges are taking a shot at Cardiac Therapeutic Agents. As of late three new medications were presented in 2015. There are numerous kinds of cardiovascular medications in the market that incorporate Cardiac glycosides, enemies of coagulants, against arrhythmic operators, hostile to anginal specialists and against hypertensive specialists.

 

  • Drug-Induced Cardiac Toxicity
  • Novel Anti-Inflammatory Therapies for Atherosclerosis
  • Development of Novel Anti-Ischaemic Agents
  • Beta Blockers Blocking
  • Cardiac Glycoside

Related Conference of Heart Pharmacology

July 27-28, 2026

12th International Heart Conference

Dubai, UAE
July 29-30, 2026

30th World Cardiology Conference

Paris, France
August 17-18, 2026

4th International Conference on World Heart Care

Toronto, Canada
August 27-28, 2026

40th European Cardiology Conference

Berlin, Germany
October 20-21, 2026

15th World Heart Congress

London, UK
November 09-10, 2026

7th Annual Summit on Cardiology and Heart Diseases

Paris, France
November 16-17, 2026

8th World Heart Congress

Tokyo, Japan
November 16-17, 2026

5th Global Summit on Cardiology and Cardiac Surgery

Tokyo, Japan
November 23-24, 2026

40th World Congress on Heart Diseases

Toronto, Canada
November 25-26, 2026

33rd World Heartcare Summit

Paris, France
March 18-19, 2027

16th World Heart Congress

Paris, France